Pular para o conteúdo
Merck

Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release.

Biomaterials (2008-07-29)
Gregory W Charville, Evan M Hetrick, Carri B Geer, Mark H Schoenfisch
RESUMO

The ability of nitric oxide (NO)-releasing xerogels to reduce fibrinogen-mediated adhesion of Staphylococcus aureus, Staphylococcus epidermidis, and Escherichia coli is described. A negative correlation was observed between NO surface flux and bacterial adhesion for each species tested. For S. aureus and E. coli, reduced adhesion correlated directly with NO flux from 0 to 30 pmol cm(-2)s(-1). A similar dependence for S. epidermidis was evident from 18 to 30 pmol cm(-2)s(-1). At a NO flux of 30 pmol cm(-2)s(-1), surface coverage of S. aureus, S. epidermidis, and E. coli was reduced by 96, 48, and 88%, respectively, compared to non-NO-releasing controls. Polymeric NO release was thus demonstrated to be an effective approach for significantly reducing fibrinogen-mediated adhesion of both gram-positive and gram-negative bacteria in vitro, thereby illustrating the advantage of active NO release as a strategy for inhibiting bacterial adhesion in the presence of pre-adsorbed protein.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Tetra-hidrofurano, inhibitor-free, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Tetra-hidrofurano, contains 250 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
Tetra-hidrofurano, ReagentPlus®, ≥99.0%, contains 250 ppm BHT as inhibitor
Sigma-Aldrich
Tetra-hidrofurano, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%
Sigma-Aldrich
Tetra-hidrofurano, anhydrous, ≥99.9%, inhibitor-free
Sigma-Aldrich
Tetra-hidrofurano, anhydrous, contains 250 ppm BHT as inhibitor, ≥99.9%
Sigma-Aldrich
Tetra-hidrofurano, ACS reagent, ≥99.0%, contains 250 ppm BHT as inhibitor
Supelco
Tetra-hidrofurano, HPLC grade, ≥99.9%, inhibitor-free
Supelco
Tetra-hidrofurano, analytical standard
Supelco
Tetra-hidrofurano, Selectophore, ≥99.5%